Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Mind Medicine Inc (NASDAQ: MNMD) closed at $7.69 in the last session, up 0.52% from day before closing price of $7.65. In other words, the price has increased by $0.52 from its previous closing price. On the day, 0.95 million shares were traded.
Ratios:
We take a closer look at MNMD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.27 and its Current Ratio is at 7.27. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Evercore ISI on January 28, 2025, initiated with a Outperform rating and assigned the stock a target price of $23.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when Barrow Robert sold 21,208 shares for $6.74 per share. The transaction valued at 142,942 led to the insider holds 856,556 shares of the business.
Karlin Daniel sold 6,836 shares of MNMD for $46,075 on Mar 25 ’25. The Chief Medical Officer now owns 446,177 shares after completing the transaction at $6.74 per share. On Mar 25 ’25, another insider, Sullivan Mark, who serves as the Chief Legal Officer of the company, sold 6,576 shares for $6.74 each. As a result, the insider received 44,322 and left with 316,621 shares of the company.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $10.44, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 20.50%, while the 200-Day Moving Average is calculated to be 14.28%.
Shares Statistics:
A total of 75.51M shares are outstanding, with a floating share count of 72.82M. Insiders hold about 3.61% of the company’s shares, while institutions hold 54.05% stake in the company.
Earnings Estimates
A comprehensive evaluation of Mind Medicine Inc (MNMD) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.3 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$1.19 and -$1.6 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.53, with 7.0 analysts recommending between -$0.6 and -$1.95.
